Analyst Call Rescheduled to April 26, 2016
April 19 2016 - 1:27PM
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has
postponed its analyst call scheduled for today, April 19, 2016, due
to the unavailability of its Chief Executive Officer, Matthew J.
Pfeffer. Mr. Pfeffer was diagnosed overnight with a retinal
detachment, and is undergoing emergency surgery this morning to
correct the condition.
The company has rescheduled the analyst call to
discuss its commercial strategy to April 26, 2016 at 5:00 pm
(Eastern Time).
To participate in the live call by telephone,
please dial (888) 224-7957 or (303) 223-4394 and use the
participant passcode: 21809665. Those interested in listening to
the conference call live via the Internet may do so by visiting the
Company's website at http://www.mannkindcorp.com.
A telephone replay of the call will be
accessible for approximately 14 days following completion of the
call by dialing (800) 633-8284 or (402) 977-9140 and use the
participant passcode: 21809665. A replay will also be
available on MannKind's website for 14 days.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD)
focuses on the discovery and development of therapeutic products
for patients with diseases such as diabetes. MannKind
maintains a website at www.mannkindcorp.com to which MannKind
regularly posts copies of its press releases as well as additional
information about MannKind. Interested persons can subscribe on the
MannKind website to e-mail alerts that are sent automatically when
MannKind issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other
information to the website.
Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Apr 2023 to Apr 2024